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Introduction
The safety of water supplies is of paramount 
public health importance. An estimated 
13% of the world population lacked access 
to improved drinking- water sources in 2008 
[UNICEF and World Health Organization 
(WHO) 2011], and almost 10% of the total 
burden of disease worldwide could be pre-
vented by improving drinking- water supply, 
sanitation, hygiene, and the management of 
water resources (Prüss-Üstün et al. 2008). 
Microbiological contamination is the largest 
cause of waterborne disease at a global scale. 
However, chemicals in water supplies can be 
related to health risks, generally when associ-
ated with long-term exposures (Thompson 
et al. 2007).
There are uncertainties about the safety 
of current standards for some regulated 
chemicals, and the potential health impacts 
of unregulated or emerging chemical con-
taminants are largely unknown. In May 
2012, a workshop was held at the Centre for 
Research of Environmental Epidemiology 
(CREAL), Barcelona, Spain, with the aim 
of advancing the field of epidemiology and 
chemical contaminants in water and to 
make recommendations for future research. 
Our aspiration was that the proposed sug-
gestions be useful and applicable to any 
type of chemical contaminant occurring in 
drinking water. Chemicals that we discuss as 
examples in this review are substances whose 
main pathway of human exposure is through 
drinking water. Although the chemical uni-
verse is broad and most chemicals do not 
occur exclusively in drinking water, water is 
essential for life, and exposures to chemicals 
in drinking water, even at low concentra-
tions, may have important consequences 
across the entire population. Here we focus 
on cancer as an example and summarize the 
main discussion points and conclusions of 
the workshop.
Occurrence
Regulated chemicals. Drinking- water quality 
is regulated in most countries, and moni-
toring is conducted routinely. A complete 
list of chemicals that are currently regu-
lated in drinking water, and the regulatory 
limits promul gated for each chemical by 
the WHO (2011), the U.S. Environmental 
Protection Agency (EPA 2009), and the 
European Union (EU) Council (1998) are 
provided in Table 1. These regulatory guide-
lines require periodic review to be updated 
according to new evidence. For example, the 
U.S. EPA reduced its maximum contami-
nant level (MCL) for arsenic from 50 μg/L 
in 1942 to the current level of 10 μg/L in 
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Background: Safe drinking water is essential for well-being. Although microbiological 
 contamination remains the largest cause of water-related morbidity and mortality globally, chemi-
cals in water supplies may also cause disease, and evidence of the human health consequences is 
 limited or lacking for many of them.
oBjectives: We aimed to summarize the state of knowledge, identify gaps in understanding, 
and provide recommendations for epidemiological research relating to chemicals occurring in 
drinking water.
discussion: Assessing exposure and the health consequences of chemicals in drinking water is 
challenging. Exposures are typically at low concentrations, measurements in water are frequently 
insufficient, chemicals are present in mixtures, exposure periods are usually long, multiple exposure 
routes may be involved, and valid biomarkers reflecting the relevant exposure period are scarce. In 
addition, the magnitude of the relative risks tends to be small.
conclusions: Research should include well-designed epidemiological studies covering regions with 
contrasting contaminant levels and sufficient sample size; comprehensive evaluation of contaminant 
occurrence in combination with bioassays integrating the effect of complex mixtures; sufficient 
numbers of measurements in water to evaluate geographical and temporal variability; detailed 
information on personal habits resulting in exposure (e.g., ingestion, showering, swimming, diet); 
collection of biological samples to measure relevant biomarkers; and advanced statistical models to 
estimate exposure and relative risks, considering methods to address measurement error. Last, the 
incorporation of molecular markers of early biological effects and genetic susceptibility is essential 
to understand the mechanisms of action. There is a particular knowledge gap and need to evaluate 
human exposure and the risks of a wide range of emerging contaminants.
citation: Villanueva CM, Kogevinas M, Cordier S, Templeton MR, Vermeulen R, Nuckols JR, 
Nieuwenhuijsen MJ, Levallois P. 2014. Assessing exposure and health consequences of chemicals 
in drinking water: current state of knowledge and research needs. Environ Health Perspect 
122:213–221; http://dx.doi.org/10.1289/ehp.1206229
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Table 1. Regulatory limits [μg/L (except for asbestos)] for chemicals in drinking water established by the WHO (2011), the U.S. EPA (2009), and the EU Council (1998).
DBP, disinfection by-product.
aEach water system must certify annually that when it uses acrylamide and/or epichlorohydrin to treat water, the combination of dose and monomer level does not exceed the 
 levels specified, as follows: acrylamide = 0.05% dosed at 1 mg/L (or equivalent); epichlorohydrin = 0.01% dosed at 20 mg/L (or equivalent). bIncludes its chloro-s-triazine metabolites. 
 cIncludes the sum of monochloroacetic acid, dichloroacetic acid, trichloroacetic acid, monobromoacetic acid, and dibromoacetic acid.
Chemical WHO U.S. EPA EU 
Chemical 
group
Acrylamide 0.5 a 0.1 Organic
Alachlor 20 2 — Organic
Aldicarb 10 — — Organic
Aldrin + dieldrin 0.03 — — Organic
Antimony 20 6 5.0 Inorganic
Arsenic 10 10 10 Inorganic
Asbestos (million fibers >10 μm per liter) — 7 — Inorganic
Atrazine 100b 3 — Organic
Barium 700 2,000 — Inorganic
Benzene 10 5 1.0 Organic
Benzo[a]pyrene 0.7 0.2 0.010 Organic
Berylium — 4 — Inorganic
Boron 2,400 — 1,000 Inorganic
Bromate 10 10 10 DBP
Bromodichloromethane 60 — — DBP
Bromoform 100 — — DBP
Cadmium 3 5 5.0 Inorganic
Carbofuran 7 40 — Organic
Carbon tetrachloride 4 5 — Organic
Chloramines (as Cl2) — 4,000 — Disinfectant
Chlorate 700 — — DBP
Chlordane 0.2 2 — Organic
Chlorine 5,000 4,000 — Disinfectant
Chlorine dioxide — 800 — Disinfectant
Chlorite 700 1,000 — DBP
Chlorobenzene — 100 — Organic
Chloroform 300 — — DBP
Chlorotoluron 30 — — Organic
Chlorpyrifos 30 — — Organic
Chromium (total) 50 100 50 Inorganic
Copper 2,000 13,000 2,000 Inorganic
Cyanazine 0.6 — — Organic
Cyanide — 200 50 Inorganic
2,4-D (dichlorophenoxyacetic acid) 30 70 — Organic
Dalapon — 200 — Organic
2,4-DB (dichlorofenoxybutyric acid) 90 — — Organic
DDT (dichlorodiphenyltrichloroethane) 
and metabolites
1 — — Organic
Dibromochloromethane 100 — — DBP
1,2-Dibromo-3-chloropropane (DBCP) 1 0.2 — Organic
1,2-Dibromoethane 0.4 — — Organic
Dichloroacetate 50 — — DBP
Dichloroacetonitrile 20 — — DBP
1,2-Dichlorobenzene (o-dichlorobenzene) 1,000 600 — Organic
1,4-Dichlorobenzene (p-dichlorobenzene) 300 75 — Organic
1,2-Dichloroethane 30 5 3.0 Organic
1,2-Dichloroethene 50 — — Organic
1,1-Dichloroethylene — 7 — Organic
cis-1,2-Dichloroethylene — 70 — Organic
trans-1,2-Dichloroethylene — 100 — Organic
Dichloromethane 20 5 — Organic
1,2-Dichloropropane 40 5 — Organic
1,3-Dichloropropene 20 — — Organic
Dichlorprop 100 — — Organic
Di(2-ethylhexyl) adipate — 400 — Organic
Di(2-ethylhexyl) phtalate 8 6 — Organic
Dimethoate 6 — — Organic
Dinoseb — 7 — Organic
1,4-Dioxane 50 — — Organic
Dioxin (2,3,7,8-TCDD) — 0.00003 — Organic
Diquat — 20 — Organic
Edetic acid 600 — — Organic
Endothall — 100 — Organic
Chemical WHO U.S. EPA EU 
Chemical 
group
Endrin 0.6 2 — Organic
Epichlorohydrin 0.4 a 0.10 Organic
Ethylbenzene 300 700 — Organic
Ethylene dibromide — 0.05 — Organic
Fenoprop/Silvex/2,4,5-TP/2-(2,4,5- 
trichlorophenoxy)propionic acid
9 50 — Organic
Fluoride 1,500 4,000 1,500 Inorganic
Glyphosate — 700 — Organic
Haloacetic acids (HAAs)c — 60 — DBP
Heptachlor — 0.4 — Organic
Heptachlor epoxide — 0.2 — Organic
Hexachlorobenzene — 1 — Organic
Hexachlorobutadiene 0.6 — — Organic
Hexachlorocyclopentadiene — 50 — Organic
Hydroxyatrazine 200 — — Organic
Isoproturon 9 — — Organic
Lead 10 15 10 Inorganic
Lindane 2 0.2 — Organic
Mecoprop 10 — — Organic
Mercury 6 2 1.0 Inorganic
4-(2-Methyl-4-chlorophenoxy) acetic acid 
(MCPA)
2 — — Organic
Methoxyclor 20 40 — Organic
Metolachlor 10 — — Organic
Microcystin-LR 1 — — Algal toxin
Molinate 6 — — Organic
Monochloramine 3,000 — — Disinfectant
Monochloroacetate 20 — — DBP
Nickel 70 — 20 Inorganic
Nitrate 50,000 45,000 50,000 Inorganic
Nitrilotriacetic acid 200 — — Organic
Nitrite 3,000 4,500 500 Inorganic
N-Nitrosodimethylamine (NDMA) 0.1 — — DBP
Oxamyl (Vydate®) — 200 — Organic
Pendimethalin 20 — — Organic
Pentachlorophenol 9 1 — Organic
Pesticides — — 0.10 Organic
Pesticides (total) — — 0.50 Organic
Picloram — 500 — Organic
Polychlorinated biphenyls (PCBs) — 0.5 — Organic
Polycyclic aromatic hydrocarbons — — 0.10 Organic
Selenium 40 50 10 Inorganic
Simazine 2 4 — Organic
Sodium dichloroisocyanurate/
cyanuric acid
50,000/ 
40,000
— — Disinfectant
Styrene 20 100 — Organic
Tertbutylazine 7 — — Organic
Tetrachloroethene (tetrachloroethylene) 40 5 — Organic
Tetrachloroethylene + trichloroethylene — — 10 Organic
Thallium — 2 — Inorganic
Toluene 700 1,000 — Organic
Toxaphene — 3 — Organic
Trichloroacetate 200 — — DBP
1,2,4-Trichlorobenzene — 70 — Organic
1,1,1-Trichloroethane — 200 — Organic
1,1,2-Trichloroethane — 5 — Organic
Trichloroethene/trichloroethylene 20 5 — Organic
2,4,6-Trichlorophenol 200 — — Organic
2,4,5-T (2,4,5-trichlorophenoxyacetic acid) 9 — — Organic
Trifluralin 20 — — Organic
Trihalomethanes (total) — 80 100 DBP
Vinyl chloride 0.3 2 0.50 Organic
Xylenes 500 10,000 — Organic
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response to growing scientific evidence of 
its adverse health effects (Smith et al. 2002). 
Epidemiological studies have reported asso-
ciations of trihalomethane (THM) levels in 
drinking water (a surrogate measure of the 
disinfection by-product mixture) and blad-
der cancer (Villanueva et al. 2004) at THM 
levels lower than the current regulations in 
the United States and the European Union 
(80 and 100 μg/L, respectively; Table 1). The 
current MCL for nitrate was set based on 
methemoglobinemia among infants, but there 
is uncertainty concerning the safety of this 
MCL for chronic effects over longer exposure 
periods (e.g., on cancer) (Ward et al. 2005). 
Manganese is a neurotoxin associated with 
learning disabilities and deficits in intellec-
tual function in children (Zoni and Lucchini 
2013). The WHO manganese guideline has 
been fluctuating from the initial 500 μg/L 
in 1958 (Ljung and Vahter 2007) to its dis-
continuation in the current (fourth) edition 
of the WHO guidelines (WHO 2011). This 
has generated controversy in the scientific 
community because the last guideline before 
discontinuation (400 μg/L) was questionable 
according to some authors (Ljung and Vahter 
2007) and the discontinuation of the manga-
nese guidelines has received criticisms (Frisbie 
et al. 2012). Although many contaminants 
are monitored and regulated, the adequacy of 
the MCL approach is open to debate, in part 
because these limits are often based on toxico-
logical studies of animals because human 
studies are not available or are inconclusive.
Emerging chemical contaminants. Non-
regulated chemicals are of particular con-
cern and constitute a main focus of current 
research (Richardson and Ternes 2011). 
Wastewater from human activities may con-
taminate water supply sources with pharma-
ceuticals, nano particles, consumer products 
(such as sunscreens), and other contaminants 
(Table 2), and these chemicals have been 
identified in drinking water (Ternes 2007). 
For example, iodinated or nitrogenated dis-
infection by-products (DBPs) [which are 
unregulated DBPs that are more toxic than 
their chlorinated and carbonaceous DBP 
analogs (Plewa et al. 2008b)] may occur in 
water supplies at very low concentrations 
(Plewa et al. 2004, 2008a). Degradation by-
products of pharmaceuticals, which may be 
more toxic than their parent compounds, 
also have been identified in drinking water 
(Shen and Andrews 2011). The contribution 
of drinking water as a source of exposure to 
perfluorinated chemicals may be as impor-
tant as dietary intake (Ericson et al. 2008), 
and evidence suggests that continued human 
exposure to even relatively low concentrations 
of perfluoro octanoic acid (PFOA) in drink-
ing water results in elevated body burdens 
that may increase the risk of health effects 
(Post et al. 2012). Although concentra-
tions are generally low (usually in the range 
of nanograms per liter) and some individual 
chemicals may pose no appreciable risks to 
human health (Schriks et al. 2010), there are 
concerns about potential risks of exposures 
to mixtures (Silva et al. 2002). The removal 
efficiency by drinking- water treatment pro-
cesses has been evaluated for some substances 
(WHO 2012) but is poorly known for many 
emerging pollutants.
Global Indicators of Toxicity
Water supplies often include mixtures of 
chemical contaminants that vary in time and 
space. In addition, the epidemiological and 
toxicological evaluation of mixtures involves 
significant challenges, in many cases beyond 
the limits of current research methods. 
In vitro bioassays (or biosensors) developed 
through toxicological research are promis-
ing tools for measuring the global toxicity 
of chemical mixtures in water samples and 
may be coupled with more in-depth analy-
sis of specific contaminants when a positive 
response is detected. For example, Jeong 
et al. (2012) evaluated in vitro mamma-
lian cell toxicity for a range of DBPs in an 
attempt to identify specific DBPs responsible 
for genomic DNA damage. End points that 
can be measured by in vitro bioassays include 
mutagenicity (Ames test) (Richardson et al. 
2010), genotoxicity (micronuclei, Comet 
assay) (Plewa et al. 2010), endocrine disrup-
tion (DR-CALUX bioassay) (Brand et al. 
2013; Sato et al. 2010), and cytotoxicity 
(Plewa et al. 2010). Although the use of these 
markers is not without limitations (such as 
the need for complex and non standardized 
sample pretreatment methods in order to 
obtain concentrates before laboratory analysis 
and the uncertain validity for some of the 
assays, limited throughput development, ele-
vated cost, low sensitivity, and results reflect-
ing only short-term exposure evaluations). 
Further development of these techniques 
and their incorporation into epidemio logical 
research may improve our understanding 
of the effects of mixtures. These efforts will 
require improved, interdisciplinary communi-
cation and collaboration including analytical 
chemists, toxicologists, and epidemiologists.
Human Exposure
Accurate exposure assessment in human 
observational studies is essential to obtain 
valid results and constitutes a main methodo-
logical challenge, as summarized in Table 3. 
Difficulties in identifying and measuring 
contaminants in water supplies at very low 
concentrations and substances occurring in 
mixtures hamper the evaluation of human 
exposure, requiring new methods in health 
risk analysis (Schwarzenbach et al. 2006).
DBPs are an example of chemicals occur-
ring in complex mixtures, and this has been 
addressed in part by using a few compounds 
as surrogates for the DBP mixture as a whole. 
For example, observational studies of human 
DBP exposures and health effects have focused 
on a small subset of the several hundred 
DBPs that may occur in public water sup-
plies (Richardson et al. 2007), particularly the 
THMs and haloacetic acids (HAAs) (Hinckley 
et al. 2005; Hoffman et al. 2008; Righi et al. 
2012). However, although these compounds 
are often used as a surrogate for other DBPs, 
the assumption that they correlate with other 
DBPs is not universally supported, and corre-
lations can vary in time and space (Villanueva 
et al. 2012).
Methods of exposure assessment are influ-
enced by the specific outcome under study. 
For instance, for end points with a long 
latency, such as cancer, long time periods of 
more than several decades need to be evalu-
ated, whereas for reproductive outcomes, it 
is very important to accurately capture the 
temporal variation in exposure over a shorter 
period covering the relevant time windows 
before and during gestation.
Chemicals or metabolites have been mea-
sured in biological samples in epidemiological 
studies to estimate exposures [e.g., urinary or 
toenail arsenic measurements in cancer stud-
ies (Karagas et al. 2004)]. Urinary trichloro-
acetic acid is a promising biomarker of DBPs 
that requires methodological development 
before a generalized use in epidemiological 
studies (Savitz 2012). In addition, among the 
available biomarkers specific for drinking- 
water contaminants, many have short half-
lives (e.g., urinary trichloro acetic acid) and 
are thus of limited value to associate with 
health outcomes that require long-term expo-
sures (Savitz 2012). Consequently, exposure 
assessment in most instances relies on assess-
ing personal behavior (ascertained through 
questionnaires) and measuring environmental 
levels of the chemicals (Hoffman et al. 2008; 
Levallois et al. 2012).
Inhalation and dermal contact may be 
relevant exposure routes for volatile or skin-
permeable chemicals. In such cases, activities 
involving different water uses at home (e.g., 
showering, bathing), in recreation (e.g., swim-
ming in pools), and through occupations 
involving water contact should be considered.
Alternative methods of exposure assess-
ment may involve statistical modeling; for 
example, modeling based on known geo-
graphic distributions of contaminants 
(Toledano et al. 2005), hydrological model-
ing of under ground plumes of contami-
nants (Gallagher et al. 2010), and/or the 
use of surrogate parameters such as land use 
(Aschebrook-Kilfoy et al. 2012). Several 
methods can be used in combination, tailored 
Villanueva et al.
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to the availability of data; for example, in a 
recent study on the long-term exposure to 
arsenic and cancer, Nuckols et al. (2011) 
combined arsenic data from their own mea-
surements in water samples collected at homes 
of the participants, data from public water 
utilities, and historical data for aquifers.
Exposure estimates with minimal mea-
surement error are necessary to produce valid 
effect estimates. Misclassification of exposure 
is of particular concern at the low exposure 
range because it tends, under most scenar-
ios, to attenuate associations toward the null 
(Cantor and Lubin 2007; Waller et al. 2001) 
or to reduce the precision of associations 
(Wright and Bateson 2004). Strategies to min-
imize measurement error are necessary from 
study design to data analysis, and include, for 
example, the collection of repeated measures 
of individual water use over the relevant expo-
sure period (Forssen et al. 2009) and assessing 
reliability of interviews to exclude unreliable 
questionnaires (Villanueva et al. 2009).
Health Effects
The following is an overview of epidemiologi-
cal findings from individual-based studies of 
chemical contaminants in water and cancer. 
Table 4 displays a summary of the evidence of 
carcinogenicity as evaluated and concluded by 
the WHO International Agency for Research 
on Cancer (IARC).
There is sufficient evidence in humans 
that arsenic in drinking water causes cancers 
of the urinary bladder, lung, and skin (IARC 
2004). Studies conducted in areas with lower 
levels of arsenic in drinking water (i.e., at 
or below the MCL) have reported inconsis-
tent results, and cancer risks associated with 
exposure to low arsenic levels over decades 
remain uncertain.
Bladder cancer has been consistently asso-
ciated with DBP exposure (Cantor 2010), 
and pooled analyses combining data from 
studies conducted in different countries have 
reported associations between bladder can-
cer and THM at levels below current MCLs 
(Costet et al. 2011; Villanueva et al. 2004). 
Some (Cragle et al. 1985; King et al. 2000; 
Wilkins and Comstock 1981), but not all 
(Doyle et al. 1997; Hildesheim et al. 1998; 
Table 2. Emerging chemical contaminants that may occur in water sources or treated drinking water [data from Richardson and Ternes (2011)], with the current 
state of information regarding their health effects.
Chemical group Source Chemicals
Suspected or known  
health effects
Algal toxins Produced by algal blooms from an excess of nutrients 
(in agricultural runoff and wastewater discharges).
Microcystins (e.g., microcystin-LR), nodularins, 
anatoxins, cylindrospermopsin, and saxitoxins.
Microscystin-LR is hepatotoxic, 
genotoxic, and carcinogenic 
(IARC 2010).
Artificial sweeteners Consumers > urban wastewater > natural waters > 
drinking- water source.
Sucralose (Splenda®, SucraPlus™), acesulfame, 
saccharin, cyclamate, etc.
Unknown. Sucralose is a 
persistent chemical in the 
environment (half-life up to 
several years).
Brominated flame 
retardants
Used during many years in commercial products such 
as children’s sleepwear, foam cushions in chairs, 
computers, plastics, and electronics. Diet is a 
source of exposure because some are persistent and 
accumulate in fish, eggs, milk, and meat.
Several chemicals classified in different groups 
such as polybrominated diphenyl ethers 
(PBDEs), polybrominated biphenyl (PBB), 
hexabromocyclododecane (HBCD).
Neurotoxicity and thyroid 
disruption (Dingemans et al. 
2011).
Benzotriazoles Complexing agents widely used as anticorrosives and 
for silver protection in dishwashing liquids.
The two most common forms are benzotriazole and 
tolytriazole.
Unknown. Soluble in water, 
resistant to biodegradation, 
and only partly removed in 
wastewater treatment.
DBPs Generated through chemical reaction between organic 
matter and a disinfectant (e.g., chlorine, chloramine, 
chlorine dioxide) in the treatment of drinking water 
and swimming pools.
More than 700 compounds identified to date, which 
together are estimated to account for ~ 50% of the 
total organic halogen content.
Genotoxic, carcinogenic, 
reprotoxic.
Ionic liquids Organic salts with low melting point (< 100ºC) 
promoted as “green chemistry” replacements to 
traditional solvents in industry. They exhibit some 
unique properties, including tunable viscosity, 
miscibility, and electrolytic conductivity, which make 
them useful for many applications, including organic 
synthesis and catalysis, production of fuel cells, 
batteries, coatings, oils, and nanoparticles, as well 
as other chemical engineering and biotechnology 
applications.
The chemical structures typically involve a cationic 
or anionic polar head group with accompanying 
alkyl side chains. Cationic head groups 
include imidazolium, pyridinium, pyrrolidinium, 
morpholinium, piperidium, quinolinium, quaternary 
ammonium, and quaternary phosphonium 
moieties; anionic head groups include 
tetrafluoroborate (BF4–), hexafluorophosphate (PF6–), 
bis(trifluoromethylsulfonyl)-imide [(CF3SO2)2N–], 
dicyanamide [(CN)2N–], chloride, and bromide.
Different toxicity in animals 
(Pham et al. 2010). No human 
studies.
Illicit drugs Found in surface waters, but generally removed by 
treatment in water utilities (Huerta-Fontela et al. 
2008).
Several chemicals, including amphetamine-like 
compounds, benzodiazepines, cannabinoids, 
cocainics, lysergic acid diethylamine (LSD), opioids, 
and metabolites (Valcárcel et al. 2012).
The effect of the mixture is 
unknown.
Musks Highly lipophilic chemicals widely used as fragrance 
additives in many consumer products including 
perfumes, lotions, sunscreens, deodorants, and 
laundry detergents.
Several chemicals. May have nitroaromatic structures 
[as in the case of musk xylene (1-tert-butyl-3,5-
dimethyl-2,4,6-trinitrobenzene) or musk ketone 
(4-tert-butyl-2,6-dimethyl-3,5-dinitroacetophenone)] 
or polycyclic structures [as in the case of 7-acetyl-
1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphthalene 
(AHTN; trade name, tonalide), 1,3,4,6,7,8-hexahydro-
4,6,6,7,8,8-hexamethylcyclopenta-(g)-2-benzopyran 
(HHCB; trade name, galaxolide), 4-acetyl-6-tert-butyl-
1,1-dimethylindan (ADBI; trade name, celestolide), 
dihydropentamethylindanone (DPMI; trade name, 
cashmeran), or 5-acetyl-1,1,2,3,3,6-examethylindan 
(AHMI, trade name phantolide)].
Endocrine disruption, according 
to animal evidence (Schreurs 
et al. 2004).
Continued
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Koivusalo et al. 1997), studies of DBP expo-
sure and colon cancer have reported positive 
associations. Similarly, positive associations 
for DBP exposure have been found for rectal 
cancer (Bove et al. 2007; Doyle et al. 1997; 
Hildesheim et al. 1998) not replicated in 
other studies (King et al. 2000; Koivusalo 
et al. 1997; Wilkins and Comstock 1981).
The epidemiological investigation for 
nitrate and cancer has been challenging. 
Drinking water may be a primary source of 
nitrate exposure when drinking- water con-
centrations are > 50 mg/L (IARC 2010). 
Below this threshold, diet is the main expo-
sure route, involving complex mechanisms 
of action through endogenous formation of 
N-nitroso compounds (IARC 2010). Long-
term exposure to nitrate in drinking water has 
been evaluated in relation to multiple can-
cer sites including the esophagus, stomach, 
bladder, and colon (IARC 2010). Although 
there is inadequate human evidence for car-
cinogenicity, there is sufficient evidence from 
experimental animals for the carcinogenic-
ity of nitrite in combination with amines or 
amides, and ingested nitrate under conditions 
that result in endogenous nitrosation has been 
classified as probably carcinogenic to humans 
(IARC 2010).
Other contaminants have been less exten-
sively investigated in relation to cancer risk. 
Fluoride is added to drinking water at low 
concentrations in some countries to prevent 
dental caries, and naturally occurs in water at 
higher levels in certain parts of the world such 
as the Rift Valley in Africa (Malde et al. 2011). 
The IARC (1987) evaluated fluoride carcino-
genicity and concluded that human and ani-
mal evidence was inadequate (Table 3). Some 
epidemiological studies on osteosarcoma have 
been published after this evaluation (Bassin 
et al. 2006; Kim et al. 2011), but consistent 
associations have not been observed.
The liver is a target organ for microcystin-
LR (IARC 2010), which are toxins produced 
by cyanobacteria as a result of algae blooms 
and the eutrophication of surface waters. 
Individual-based studies evaluated by IARC 
(2010) have assessed exposure by comparing 
water consumed from ponds or ditches versus 
other sources and no measurements of toxins 
or bacteria were considered. In consequence, 
IARC concluded that evidence in humans 
for the carcinogenicity of microcystin-LR is 
inadequate (IARC 2010). Other carcinogens 
such as heavy metals, pesticides, and solvents 
may occur in drinking water as a consequence 
of human activities and natural hydrogeo-
chemical processes. However, evidence on the 
cancer risk on human populations is limited.
Mechanisms and Biomarkers
The elucidation of mechanisms of action 
to provide biological plausibility and sup-
port causality suggested by epidemiological 
associations is a priority in current research. 
Biomarkers of early effect can be used in 
epidemiological studies to provide evidence 
about subclinical or intermediate effects 
Table 2. Continued.
Chemical group Source Chemicals
Suspected or known  
health effects
Naphtenic acids Result from petroleum extraction. Occur naturally in 
crude oil deposits across the world (up to 4% by 
weight) and in coal.
Complex mixture of alkyl-substituted acyclic and 
cyclo-aliphatic carboxylic acids that dissolve in water 
at neutral or alkaline pH and have surfactant-like 
properties.
Liver toxicity in mammals 
(Rogers et al. 2002). No human 
studies.
Nanomaterials Heterogeneous group of chemicals sized 1–100 nm, 
highly stable, strong, conductors, and with low 
permeability.
Several chemical groups and structures including 
fullerenes, nanotubes, quantum dots, metal oxanes, 
titanium dioxide, nanoparticles, nanosilver, and 
zerovalent iron nanoparticles.
Unknown.
Perfluorinated compounds 
(PFCs)
Used to make stain repellents (such as Teflon), and 
in the manufacture of paints, adhesives, waxes, 
polishes, metals, electronics, fire-fighting foams, 
and caulks as well as grease-proof coatings for 
packaging. Diet is the main route of exposure, 
followed by drinking water, house dust, and air.
Different types. The most common are 
perfluorooctanoic acid (PFOA) and 
perfluorooctanesulfonic acid (PFOS).
Liver, pancreatic, and 
testicular tumor in animals. 
Inmunotoxicity (DeWitt 
et al. 2012), thyroid function 
disruption (Boas et al. 2012; 
Melzer et al. 2010).
Pesticide transformation 
by-products
Result from the hydrolysis, oxidation, biodegration, 
or photolysis of pesticides. Can be present at higher 
levels than the parent compound and can be as toxic 
or more toxic. Diet is a source of exposure.
Several chemicals, such as alachlor ethanesulfonic 
acid (ESA), alachlor oxanilic acid (OA), acetochlor 
ESA, acetochlor OA, metolachlor ESA, metolachlor 
OA, 3-hydroxycarbofuran, and terbufos sulfone.
Unknown.
Pharmaceuticals Human consumption > excretion > urban wastewater > 
natural waters > drinking- water source.
Several chemicals, including antidepressants, antiviral 
drugs, glucocorticoids, antimycotics, antibiotics, 
beta-blockers.
The effect of the mixture is 
unknown.
Siloxanes Used in cosmetics, deodorants, soaps, hair 
conditioners, hair dyes, car waxes, baby pacifiers, 
cookware, cleaners, furniture polishes, and water-
repellent windshield coatings.
Cyclic siloxanes [octamethylcyclotetrasiloxane 
(D4), decamethylcyclopentasiloxane (D5), 
dodecamethylcyclohexasiloxane (D6), and 
tetradecamethylcycloheptasiloxane (D7)] and linear 
siloxanes.
Unknown.
Sunscreens/ultraviolet 
filters
Personal care products > urban wastewater > natural 
waters > drinking- water source. Identified in 
drinking water (in Barcelona, Spain) with average 
concentrations up to 295 ng/L (Díaz-Cruz et al. 2012).
Several chemicals. The ones identified in drinking 
water are benzophenone-3 (BP3), octocrylene 
(OC), 2-ethylhexyl 4-methoxycinnamate (EHMC), 
3-(4-methylbenzylidene) camphor (4-MBC), and 
2-ethylhexyl 4-(dimethylamino) benzoate (OD-PABA).
Unknown.
Single chemicals
Dioxane High-production chemical used as a solvent stabilizer 
in the manufacture and processing of paper, cotton, 
textile products, automotive coolants, cosmetics, and 
shampoos and as a stabilizer of 1,1,1-trichloroethane 
(a degreasing agent).
1,4-Dioxane. Regulated by U.S. EPA (50 mg/L). Unknown.
Perchlorate Highly stable and soluble chemical used in solid 
propellants in rockets, missiles, and fireworks as well 
as in highway flares. Can be found as a contaminant 
in sodium hypochlorite. Perchlorate can accumulate 
in plants and has been found in biological samples.
Perchlorate Unknown. Perchlorate can cross 
the placenta.
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of exposures (e.g., cytogenetic changes), 
and effects of very low exposure levels, and 
they can be used in experimental studies to 
evaluate the effect of an intervention. For an 
intermediate biomarker to be informative, 
it should be associated with both the disease 
and exposure of interest and reflect an inter-
mediate step in the pathway between expo-
sure and disease. For example, a suggested 
mechanism of action for arsenic is through 
epigenetic dysregulation, although there are 
limited human studies available (Ren et al. 
2011). In addition, the evaluation of genetic 
variants may be used to identify susceptible 
populations underlying the biological mech-
anisms of action. For example, the evalua-
tion of genetic variants of DBP-metabolizing 
enzymes in an epidemiological study on blad-
der cancer and THM exposure has shown 
that polymorphisms in key metabolizing 
enzymes modified DBP-associated bladder 
cancer risk (Cantor et al. 2010). In addition, 
the consistency of these findings with experi-
mental observations of GSTT1 (glutathione 
S-transferase theta 1), GSTZ1 (glutathione 
S-transferase zeta 1), and CYP2E1 (cyto-
chrome P450, family 2, subfamily E, poly-
peptide 1) enzymatic activity strengthens the 
hypothesis that DBPs cause bladder cancer 
and suggests possible mechanisms, as well 
as the classes of compounds likely to be 
 implicated (Cantor et al. 2010).
There are few validated biomarkers spe-
cific for chemical contaminants in drink-
ing water. However, the availability of 
prospective studies with biobanked samples 
and biotechnological development allowing 
large numbers of compounds to be measured 
in small amounts of biological samples (e.g., 
urine, plasma, serum) is encouraging. These 
technologies include genomics, epigenomics, 
transcriptomics, adductomics, proteomics, 
and metabolomics (Rappaport and Smith 
2010; Wild 2005). Application of these 
techniques will facilitate a comprehensive 
approach to identify perturbations in bio-
logical systems and associated mechanisms of 
action (Moore et al. 2013). These technolo-
gies have not been widely applied in water 
research but have shown promising results in 
other areas of environmental research.
Future Challenges
A significant and growing body of evidence 
suggests that climate change will have a det-
rimental effect on the quality of water avail-
able for human consumption in the future. 
For example, increasing temperatures may 
enhance conditions for the proliferation of 
cyanobacteria and algae (Joehnk et al. 2008; 
Newcombe et al. 2012; Paerl and Huisman 
2008). Cyanobacteria are of particular con-
cern for human populations because they 
can produce cyanotoxins such as microcystin 
that have carcinogenic effects (IARC 2010). 
The frequency of extreme weather events 
is expected to increase as a consequence of 
climate change, and the concentrations of 
chemical contaminants may be affected by 
extreme precipitation events. For example, 
tests conducted in models of different types 
of soils showed that certain mobile pharma-
ceuticals occur at higher concentrations in 
soil and groundwater during and directly 
after intense precipitation events (Oppel 
et al. 2004). Simulation studies have shown 
that pesticide concentrations fluctuate with 
changes in precipitation intensity and sea-
sonality (Bloomfield et al. 2006; Probst 
et al. 2005). Evidence concerning the effect 
of drought is mixed. For example, concen-
trations of heavy metals (e.g., chrome, mer-
cury, lead, cadmium) introduced primarily 
from anthropogenic activities in the Rhine 
River basin are higher during drought years 
(Zwolsman and van Bokhoven 2007). In con-
trast, no significant changes during drought 
conditions, but significant variability between 
seasons, has been described in the Dommel 
River, a tributary of the Meuse river in the 
Netherlands where increased groundwater 
flow in winter led to increased metal con-
centrations (Wilbers et al. 2009). In sum-
mary, it is expected that climate change could 
adversely affect drinking- water quality, but 
there is limited knowledge concerning the 
magnitude and distribution of the impact at 
different scales (global, regional, local).
Final Remarks and 
Recommendations
General aspects. Although microbiological 
contamination is the largest contribution to 
waterborne disease and mortality at a global 
scale, chemical contaminants in water sup-
plies also can cause disease, sometimes after 
long periods of exposure. The concentrations 
in drinking water, the prevalence of human 
exposure in the population, and the level of 
toxicity can be used to prioritize chemicals for 
further research. These characteristics may vary 
geographically and, therefore, further research 
should be designed to local-, region-, or 
country-specific circumstances as appropriate. 
Finally, exposures and risks affecting vulner-
able populations (e.g., children and pregnant 
women) require special attention and are of 
particular interest.
Arsenic is a unique example of a substance 
in drinking water with conclusive evidence 
from human epidemiological studies. There is 
no doubt that arsenic is a human carcinogen 
at high concentrations (IARC 2004); however, 
there is inadequate information to determine 
the carcinogenic potential of other chemi-
cals that occur in drinking water (Table 4). 
Arsenic has several unique characteristics—
including the fact that drinking water rep-
resents the predominant source of exposure 
in humans; the levels in water, and thus the 
magnitude of the exposure, is very high in cer-
tain areas (e.g., Bangladesh); the availability of 
measurements in drinking water has allowed 
the development of epidemiological studies; 
Table 3. Challenges of exposure assessment for chemical contaminants in drinking water.
Challenge Comments
Low exposure levels Accuracy of analytical measurements in water is particularly important at the low range of 
exposure. In addition, detailed personal information of water use behavior is convenient.
Chemicals occurring 
in mixtures
Examples include pharmaceutical residues and disinfection by-products. Depending on the 
individual constituents of the mixture, chemical-by-chemical exposure assessment may 
not be feasible or could result in simplistic exposure estimates.
Time–space 
variability
Repeated measurements and distribution of sampling points covering different water 
zones is necessary to evaluate geographical and temporal variation during the relevant 
exposure period.
Long-term exposure 
windows
Longer exposure periods are likely to result in greater exposure misclassification. In the 
case of chronic diseases such as cancer, data collection must include accurate location 
of study participants (residence and workplace) and water use over the duration of an 
exposure period relevant to disease etiology. Combined with environmental levels, 
quantitative estimation of exposure can be conducted. An added challenge is the lack of 
historical monitoring data.
Lack of monitoring 
data
This is particularly problematic to evaluate some exposures (such as emerging 
contaminants) and some outcomes (such as cancer because historical records are 
frequently unavailable). More research is needed to develop validated simulation models 
that can be used to estimate levels and exposure over the relevant time period.
Lack of validated 
biomarkers of 
exposure
Currently available validated biomarkers typically reflect recent exposures and thus may 
not be useful for outcomes with latency periods longer than the half-life of the biomarker 
compound. Exceptions may occur if the time between consecutive exposure events is 
shorter than the elimination half-life or exposure can be regarded as constant within the 
relevant time window (such as for trichloroacetic acid).
Multiple exposure 
routes (ingestion, 
inhalation, dermal 
absorption)
Exposure to a number of water contaminants can occur through multiple routes. For example, 
some DBPs can be incorporated through inhalation, dermal absorption and ingestion. For 
other waterborne contaminants, such as nitrate (at levels in water < 50 mg/L) and per- and 
polyfluorinated compounds, diet is the main source of exposure (Ericson Jogsten 2011; 
IARC 2010). For such contaminants, exposure by all plausible routes should be assessed in 
order to produce the most accurate estimate of disease risk.
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the wide variability in exposures facilitates the 
detection of risks; the occurrence as an iso-
lated substance rather than in mixtures allows 
the direct measurement of the putative agent; 
the magnitude of the risks are high com-
pared with other chemicals; and the existence 
of biomarkers —all of which have helped to 
improve exposure assessment and elucidation 
of mechanisms of action of arsenic.
Recommendations on occurrence and expo-
sure assessment. Improved exposure assessment 
to water contaminants is essential to derive 
valid exposure– response curves and useful 
knowledge for risk assessment and regulation, 
and here we provide some suggestions.
•	The research need concerning regulated 
chemicals is to clarify the effects at or below 
their MCLs, which are suspected for some 
contaminants. Access to water utility moni-
toring data, which is necessary to conduct 
such studies, should be encouraged and 
facilitated. Access to large databases would 
facilitate improved exposure assessment 
in epidemiological studies, if the data are 
reliable and sufficient to evaluate temporal 
and geographical variations applicable to 
study areas.
•	The measurement of emerging contami-
nants needs advanced and specialized 
analytical methods, and close collaboration 
between epidemiologists and analytical 
chemists is required to provide contami-
nant occurrence data suitable in format and 
quantity for epidemiological research. Better 
communication between epidemiologists 
and environmental analytical chemists 
would facilitate human health studies in 
this area. A mechanism to converge inter-
ests might be to collect water samples for 
analytical chemistry method development 
alongside ongoing epidemiological studies, 
or training analytical chemists in exposure 
assessment procedures.
•	The evaluation of mixtures requires some 
attention in future studies because this 
remains a challenge beyond current meth-
ods. New developments may contribute to 
understand the health effects of chemical 
contaminants in drinking water.
•	Some in vitro assays as indicators of water 
toxicity are promising tools deserving 
incorporation in future studies to comple-
ment exposure assessment and health risk 
analyses. These bioassays may be espe-
cially effective to evaluate the global effect 
of chemical mixtures and identify “hot 
spots” of toxicity. Such findings can be 
useful in generating hypotheses for more 
in-depth and resource-intensive analysis of 
specific contaminants and health outcomes. 
Incorporating these methods in epidemio-
logical research should be encouraged, and 
further validation should be conducted 
when necessary.
•	Epidemiological research generally requires 
large numbers of measurements and data. 
This may constitute a challenge in the col-
laboration with analytical chemists and toxi-
cologists if experimental methods are manual 
or laborious but should be overcome in the 
future with, for example, the development of 
high-throughput techniques able to analyze 
large amounts of water samples.
•	Ongoing cohort studies should be encour-
aged to incorporate a water dimension 
because retrospective assessment is challeng-
ing, particularly for outcomes with a long 
latency such as cancer. This would require 
water sample collection, measurements, and 
personal questionnaires in ongoing cohort 
studies, and new or reinforced collabora-
tions between research groups. New cohorts 
(or data collections in existing cohorts) 
should be also encouraged to implement 
environmental sampling and storage of such 
samples (envirobanking) for use in future 
nested case–control studies.
Table 4. Evidence of carcinogenicity as concluded by the IARC for some chemicals whose main pathway of human exposure is through drinking water [modified 
from the General Remarks to IARC Monograph, Volume 101 (IARC 2012b)].
Agent Human evidence Animal evidence
Overall 
evaluationa (group) IARC Monograph
Elements
Arsenic Sufficient Sufficient 1 Vol. 100 C (IARC 2012a)
Fluoride Inadequate Inadequate 3 Suppl. 7 (IARC 1987)
Nitrate Inadequate Inadequate/sufficientb 2Ac Vol. 94 (IARC 2010)
Microcystin-LR Inadequate Inadequate 2B Vol. 94 (IARC 2010)
DBPs: Trihalomethanes
Chloroform Inadequate Sufficient 2B Vol. 73 (IARC 1999)
Bromodichloromethane Inadequate Sufficient 2B Vol. 52 (IARC 1991)
Dibromochloromethane Inadequate Limited 3 Vol. 52 (IARC 1991)
Bromoform Inadequate Limited 3 Vol. 52 (IARC 1991)
DBPs: Haloacetic acids
Dichloroacetic acid Inadequate Sufficient 2B Vol. 106 (IARC 2013)
Trichloroacetic acid Inadequate Sufficient 2B Vol. 106 (IARC 2013)
Bromochloroacetic acid Inadequate Sufficient 2B Vol. 101 (IARC 2012b)
Dibromoacetic acid Inadequate Sufficient 2B Vol. 101 (IARC 2012b)
DBPs: Halogenated acetonitriles
Bromochloroacetonitrile No data Inadequate 3 Vol. 52 (IARC 1991)
Chloroacetonitrile No data Inadequate 3 Vol. 52 (IARC 1991)
Dibromoacetonitrile No data Inadequate 3 Vol. 52 (IARC 1991)
Dichloroacetonitrile No data Inadequate 3 Vol. 52 (IARC 1991)
Trichloroacetonitrile No data Inadequate 3 Vol. 52 (IARC 1991)
Dibromoacetonitrile No data Sufficient 2B Vol. 101 (IARC 2012b)
Chloral hydrate Inadequate Sufficient 2A Vol. 106 (IARC 2013)
MX (3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone) Inadequate Limited 2Bd Vol. 84 (IARC 2004)
Bromate (evaluated as potassium bromate) Inadequate Sufficient 2B Vol. 73 (IARC 1999)
Chlorite (evaluated as sodium chlorite) No data Inadequate 3 Vol. 52 (IARC 1991)
Chlorinated drinking water Inadequate Inadequate 3 Vol. 52 (IARC 1991)
Chemicals used in the disinfection of drinking water
Hypochlorite salts No data Inadequate 3 Vol. 52 (IARC 1991)
Chloramine Inadequate Inadequate 3 Vol. 84 (IARC 2004)
aGroup 1 (the agent is carcinogenic to humans), 2A (the agent is probably carcinogenic to humans), 2B (the agent is possibly carcinogenic to humans), 3 (the agent is not classifiable 
as to its carcinogenicity to humans). bThere is sufficient evidence in experimental animals for the carcinogenicity of nitrite in combination with amines or amides. cIngested nitrate or 
nitrite under conditions that result in endogenous nitrosation is probably carcinogenic to humans. dOther relevant data were used to upgrade the evaluation.
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•	Methods developed for environmental and 
geospatial sciences, including geographi-
cal information systems and fate/transport 
modeling of chemicals, have been demon-
strated to be useful in exposure assessment 
for risk analysis for waterborne chemical 
contaminants. Consequently, greater empha-
sis on incorporating these methodologies 
into environmental epidemiological studies 
should be made.
•	Climate change is likely to affect water qual-
ity with uncertain implications for human 
health. Research to evaluate these impacts 
and the potential human health conse-
quences at different regional scales and in 
different climates is necessary.
Recommendations on epidemiological 
methods. Epidemiological studies based on 
rigorous study design are essential to prop-
erly evaluate the human health risks associ-
ated with chemical contaminants in drinking 
water. Here we summarize some suggestions 
in this direction.
•	There is a need to investigate the potential 
health outcomes of emerging (i.e., non- 
regulated) contaminants because current 
knowledge on health effects is mainly limi-
ted to regulated chemicals. However, there 
are still uncertainties and further research 
is needed to evaluate potential effects below 
MCLs for certain regulated chemicals.
•	Studies capturing widely contrasting expo-
sure levels are particularly useful to estimate 
risks. Therefore, environmental epidemiolo-
gists should influence the decision as to the 
location of study sites on this basis.
•	Large studies with sufficient statistical power 
are necessary when the expected health 
risks are small in magnitude. It is advisable 
to know contaminant levels and exposure 
prevalence before undertaking an epidemio-
logical study to allow the estimation of sam-
ple size to reach sufficient statistical power.
•	The incorporation of biomarkers of expo-
sure, effect, and genetic susceptibility in 
epidemiological studies is encouraged to 
identify molecular mechanisms of action 
and to contribute to the assessment of cau-
sality. Studies evaluating biomarkers could 
be companion studies within ongoing larger 
or small- to medium-sized experimental 
studies. In particular, -omic technologies 
can add to the current understanding of 
biological mechanisms and generate new 
hypotheses, requiring advanced and com-
plex statistical tools to deal with the large 
amounts of data generated. However, bio-
markers must be validated and biomarker 
studies generally require large numbers of 
observations and replication in multiple 
populations. Additional drawbacks of bio-
marker studies are the relatively high cost, 
the limitation of biomarkers with regard to 
capturing past exposures, their invasiveness, 
and the possibility for reverse causation (i.e., 
in cross-sectional or case–control studies).
General conclusions. Assessing the health 
impacts of chemical contaminants in drinking 
water is a challenge that requires improved 
methodologies and enhanced interdisciplinar-
ity in future epidemiological studies. Useful 
and valuable knowledge will increase if future 
studies successfully integrate existing and new 
developments from analytical chemistry, toxi-
cology, exposure science, molecular epidemiol-
ogy, statistics, environmental epidemiology, 
environmental sciences, engineering, and geo-
spatial sciences. Improved cooperation and 
collaboration with stakeholders such as the 
water industry, regulatory, and public health 
agencies and affected communities would 
serve to produce higher-quality risk analy-
ses, as well as to improve the likelihood of 
implementing effective and early intervention 
measures. Institutional support promoting 
access to reliable routine monitoring data at 
all levels and collaboration with stakeholders 
(e.g., water utilities, regulators, and consumer 
groups) would be beneficial. Finally, research 
efforts in this area are frequently hampered by 
the lack of specific funding for this research 
field, and the availability of stable and substan-
tial financial support is needed, either from 
governmental or non governmental sources.
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